The Ukrainian medtech startup, DrugCard, has entered into a partnership with the venture fund, New Nordic Ventures, securing a new financing round.
The startup's CEO, Dmytro Horilyk, made this announcement.
Dmytro Horilyk did not disclose the specific amount received from New Nordic Ventures.
"Even prior to formalising our collaboration, New Nordic Ventures provided us with valuable contacts in Latvia's pharmaceutical sector. This opened doors to key industry players in Latvia, granting us significant insights," he remarked.
Business angel Petro Chernyshov, who occasionally invests in early-stage Ukrainian startups, is also among DrugCard's investors.
